scispace - formally typeset
I

Il Sun Kim

Researcher at Yonsei University

Publications -  24
Citations -  2166

Il Sun Kim is an academic researcher from Yonsei University. The author has contributed to research in topics: Neural stem cell & Transplantation. The author has an hindex of 14, co-authored 24 publications receiving 1827 citations. Previous affiliations of Il Sun Kim include Boston Children's Hospital.

Papers
More filters
Journal ArticleDOI

Exchange-coupled magnetic nanoparticles for efficient heat induction

TL;DR: This Letter demonstrates a significant increase in the efficiency of magnetic thermal induction by nanoparticles and finds that the therapeutic efficacy of these nanoparticles is superior to that of a common anticancer drug.
Journal ArticleDOI

T 1 and T 2 dual-mode MRI contrast agent for enhancing accuracy by engineered nanomaterials

TL;DR: A dual-mode artifact filtering nanoparticle imaging agent that comprises a combination of paramagnetic and superparamagnetic nanomaterials has been developed that has the ability to perform "AND logic gate" algorithm to eliminate false errors from the raw images to enhance accuracy of the MRI.
Journal ArticleDOI

Human neurospheres derived from the fetal central nervous system are regionally and temporally specified but are not committed.

TL;DR: Even the early regional identities of human neurospheres may not be irreversible and may be altered by local inductive cues, and the properties of glial fibrillary acidic protein (GFAP)-, glutamate-, and gamma-aminobutyric acid (GABA)-expressing cells derived from neuro Spheres of the respective CNS regions appear to be regionally and temporally different.
Journal ArticleDOI

Human neural stem cells alleviate Alzheimer-like pathology in a mouse model

TL;DR: These findings demonstrate the hNSC transplantation modulates diverse AD pathologies and rescue impaired memory via multiple mechanisms in an AD model, and provide tangible preclinical evidence that human N SC transplantation could be a safe and versatile approach for treating AD patients.
Journal ArticleDOI

Clinical Trial of Human Fetal Brain-Derived Neural Stem/Progenitor Cell Transplantation in Patients with Traumatic Cervical Spinal Cord Injury

TL;DR: The transplantation of hNSPCs into cervical SCI is safe and well-tolerated and is of modest neurological benefit up to 1 year after transplants, which includes increased motor scores, recovery of motor levels, and responses to electrophysiological studies in the transplantation group.